Bio
Dr. Aditi Munmun Sengupta is a dedicated medical professional and research scholar affiliated with the University of Calcutta. With a strong foundation in Physiology and Biochemistry, she holds an MBBS, MSc in Chemistry, and a PhD. Her research interests span immune dysregulation in COVID-19, cardiovascular risk assessment, and the prevalence of infectious diseases like malaria, with a particular focus on the Indian context. Dr. Sengupta has authored several impactful papers, including works on obesity and cardiovascular risk among Bengali populations and immune dysregulation in COVID-19. She is also a Medical Officer at CK Birla Hospitals and a member of the Harvard Medical School Post Graduate Association. Her scholarly contributions have earned her recognition as a Fellow and reviewer for the Global Journal of Medical Research, reflecting her commitment to advancing medical science and public health.
Educational Journey
University of Calcutta
PhD in Department of Physiology • Department of Physiology
2026University of Calcutta
MBBS, MSc (Chem), PhD • Biochemistry
Experience
Affiliations
Indian Science Congress Association
Life member
Member since 0Harvard Medical School Post Graduate Association
Member
Member since 0Research
A Brief Study on the Prevalence of Malaria in Kolkata, West Bengal, India
Malaria has been a major public health problem in India, with cases therein contributing significantly to the overall malaria burden within South East Asia. Majority of malaria cases in India have occurred within the eastern and central regions of the country. Over 80% of the country’s total malaria cases have been reported from 10 states. Statistics for the state of West Bengal had reported approximately 26,000 and 25,000 malaria cases in 2014 and 2018, respectively, with Kolkata still being considered the most malaria-prone district of West Bengal.
A Study on Obesity and Cardiovascular Risk Assessment among the Bengali Hindu Caste Population and Tribal Population of Birbhum District, West Bengal, India
Obesity has been considered a complex and multifactorial disease that has almost affected one-third of the total world’s population. The present trend related to obesity has revealed that nearly 38% of the adults of the world’s population will suffer from the issues of being overweight by the year 2030. As per the ICMR-India study in the year 2015, the prevalence rate of obesity in India varies between 11.8% to 31.3%. The risk of cardiovascular diseases is prevalent around the world, and estimated CVD cases in the year 2015 were approximately 422.7 million, causing 17.6 million deaths (32%of global deaths) as per WHO statistics in 2016. The Indian health data of 2017 has revealed that 25.27% of the population have suffered mortality rate due to the occurrence of CVD in India. Hence, the implementation of health programs for identifying the community risk factors for preventing these diseases has evolved.
An Overview of the Immune Dysregulation in COVID-19 with Immunization Priority in the Indian Context
The review was aimed at understanding the immune dysregulation by the novel virus, COVID-19. The review also highlighted the major findings that have been published in the previous studies through secondary research about the mechanism of immune dysregulation, transmission and progression of the virus across the globe. Adults above the age of 60 years and with co-morbidities such as cardiac and renal dysfunction, hypertension and diabetes are predisposed to greater risk of COVID-19 infection. The virus impairs the physiological, psychological and metabolic functioning of the patient. The paper gained an insight into the need for immunization priority for the Indian population and recommendations for the effective policy making in vaccine development and distribution.
